Abstract
Worldwide, pregnancy at age 35 or older, termed ‘advanced maternal age (AMA)’, is increasing exponentially. As the incidence of pregnancy at AMA has increased, a growing body of evidence has suggested that AMA is also associated with increased risk for adverse maternal and fetal outcomes outside of genetic anomalies. Importantly, despite the mounting evidence and the increased global risk of adverse perinatal outcomes observed, few studies have examined the potential mechanisms underlying this elevated risk in pregnant people ≥35 years of age. Wooldridge and colleagues begin to address this gap in the literature. In their recent report, they examine vessel stiffness in omental resistance vessels obtained from pregnant individuals ≥35 years of age compared with pregnant individuals <35 years of age. Omental arteries were isolated and assessed via pressure myography (mechanical properties) and histological analysis for collagen and elastin content. Overall, the findings from this investigation report that maternal resistance arteries collected from women of AMA were less compliant and had less elastin than arteries obtained from women <35 years of age, suggesting that maternal resistance vessel stiffening in AMA may contribute to increased risk of adverse pregnancy outcomes. The authors should be commended for completing these studies in human resistance vessels, which now open new avenues for investigation and provoke a cascade of questions related to maternal cardiovascular adaptations to pregnancy in women ≥35 years of age.
Commentary
Pregnancy at age 35 or older, termed ‘advanced maternal age (AMA)’, is increasing exponentially in developed countries worldwide [1–3]. Historically, this age cutoff was defined based on evidence of declining fertility and increased risk for genetic abnormalities in the offspring of pregnant individuals over the age of 35. As the incidence of pregnancy at AMA has increased, a growing body of evidence has suggested that AMA is also associated with increased risk for adverse maternal (e.g. preeclampsia, gestational diabetes, and cesarean delivery) and fetal (e.g. small for gestational age, pre-term birth, and stillbirth) outcomes outside of genetic anomalies [2,4–6]. Although the definition of AMA begins at age 35, the risk of maternal and fetal pregnancy complications increases progressively with age beyond that point, with a drastic increase after age 40. Importantly, despite the mounting evidence and the increased global risk of adverse perinatal outcomes observed, few studies have examined the potential mechanisms underlying this elevated risk in pregnancies of AMA. The work of Wooldridge and colleagues begins to address this gap in the literature [7] and findings from their recent investigation suggest that maternal resistance arteries collected from pregnant women ≥35 years of age were less compliant and had less elastin than arteries obtained from women <35 years of age. Their findings suggest that alterations in maternal resistance vessel stiffness may contribute to increased risk of adverse maternal and fetal outcomes associated with pregnancy at AMA. The authors should be commended for extending prior work in preclinical models to this study of human resistance vessels, which provokes a cascade of questions related to pre-pregnancy vascular function and maternal cardiovascular adaptations to pregnancy in women of AMA.
Arterial stiffness describes the rigidity of the arterial wall and the mechanical properties of the arterial vascular system [8]. Arterial stiffening develops from a complex interaction including functional changes in endothelial function and sympathetic nerve activity, and structural remodeling in the arterial wall including changes in collagen and elastin content and wall thickness [9–11]. Importantly, in vivo measures of arterial stiffness are the summation of these functional and structural factors, while in vitro measures are limited to assessments of the structural components. Of particular interest to the investigation by Wooldridge et al., arterial stiffness assessed in vivo and in vitro is known to increase with age [12] and is closely associated with cardiovascular disease risk and mortality [13]. Furthermore, increased vascular stiffness assessed in vivo in early pregnancy is associated with the development of adverse pregnancy outcomes such as preeclampsia [14,15]. In their in vitro approach, Wooldridge et al. [7] obtained omental adipose tissue during scheduled cesarean delivery at term (∼38–39 weeks gestation), isolated omental arteries from this biopsy, and examined collagen and elastin content – the main components of the extracellular matrix within the vascular wall. Previous studies have shown that aging leads to the overproduction of collagen and the degradation of elastin, which contributes to arterial stiffening [16]. Wooldridge et al. also assessed passive mechanical properties (circumferential stress and strain) in vitro in isolated omental arteries from pregnant women using pressure myography. Their results showed that elastin content and circumferential strain were lower in AMA compared with pregnant individuals <35 years of age, but collagen content and circumferential stress were not different between groups. However, it should be noted that whether the changes in circumferential stress contributed to differences in the incremental elastic modulus between groups was not assessed. These findings suggest that pregnant women of AMA have increased structural stiffness of resistance arteries at term. Wooldridge et al. postulate that this increased stiffness may contribute to the heightened incidence of adverse maternal and fetal outcomes in pregnancy at AMA. However, whether this reflects an age-associated increase in pre-pregnancy resistance artery stiffness, a maladaptation to the cardiovascular demands of the pregnancy, or a combination of the two, remains unknown.
Although the relation between chronological aging and arterial stiffness is well established, the majority of the data demonstrating this relation focuses on individuals over the age of 60 years and none, to our knowledge, have include pregnant people. Therefore, it is important to highlight the fact that while age ≥35 is considered ‘AMA’, the individuals included in this group had a mean age of 38 years and would be considered ‘young’ in many studies of vascular aging. One of the most novel pieces of the study by Wooldridge and colleagues was their examination of the structural characteristics of resistance (omental) arteries in AMA. Arterial stiffening with aging is not uniform along the arterial tree, due in part to the fact that large arteries such as the aorta have more elastic tissue while resistance arteries have more vascular smooth muscle [17]. Cross-sectional studies illustrate a stronger relation between aortic stiffness and age than that between resistance artery stiffness and age [18,19]. While large artery stiffness is a well-established indicator of age-related cardiovascular events [20], whether this is true for resistance vessels, such as the omental vessels assessed in this study, remains unclear. Therefore, future studies examining the interaction between maternal age and preexisting arterial stiffness are needed.
Alternative to differences in pre-pregnancy stiffness, the authors hypothesize that their findings may reflect differences in cardiovascular adaptations to pregnancy at an AMA. Given the relatively young (compared with aging across the lifespan) and otherwise healthy pre-pregnancy status of the participants included, there is a strong rational to support this hypothesis. Healthy pregnancy requires expansive adaptations in the entire cardiovascular system including decreases in arterial stiffness [21,22] assessed by aortic pulse wave velocity – the gold standard measurement of arterial stiffness in humans – during normal pregnancy [23]. In a previous preclinical study, these same authors reported that circumferential strain of uterine arteries isolated at the end of pregnancy was lower in aged pregnant rats compared with young pregnant rats. However, they found no differences in strain between young non-pregnant and aged non-pregnant rats, mediated by matrix metalloproteinase dysregulation of elastin and collagen and enhanced myogenic vascular tone, leading to reduced vascular compliance [24,25]. These data suggest that decreased elastin content and circumferential strain at term reflects cardiovascular maladaptation to pregnancy in AMA, rather than a baseline effect of aging. Importantly, future studies that include a pre-pregnancy measure and/or longitudinal measures of resistance artery stiffness across pregnancy in healthy women ≥35 years of age are required to fully explore whether the effects observed by Wooldridge et al. are reflective of age-associated pre-pregnancy changes or vascular maladaptation to pregnancy in AMA.
The finding that resistance artery stiffness, assessed in vitro at term, is elevated in pregnant individuals ≥35 years of age, presumably as a consequence of cardiovascular maladaptation to pregnancy, initiates a cascade of questions around the mechanisms mediating this outcome. Importantly, this study was not able to discern the role of in vivo mechanisms that may have driven the structural changes assessed in vitro. Cardiovascular adaptations to pregnancy induce a state of overall reduced total peripheral resistance, mediated in part through enhanced endothelium-dependent vasodilation secondary to increased generation of endothelial-derived vasodilators such as nitric oxide and prostacyclin [26,27] in addition to the structural changes discussed above. Simultaneously, the maternal circulation is exposed to increasing sympathetic nervous system activity [28] and renin–angiotensin system activity [29] which support blood pressure and plasma volume expansion responses to facilitate enhanced blood flow. However, despite an up-regulation of these normally potent vasoconstrictor mechanisms, arterial blood pressure remains relatively stable or slightly decreases due to reductions in baroreflex gain [28] and reduced vascular angiotensin II sensitivity in healthy pregnancy [30]. Impairments in the balance of these vasodilatory and/or vasoconstrictor responses can lead to maternal complications such as gestational hypertension, preeclampsia, and gestational diabetes; however few, if any, human studies have examined normal cardiovascular adaptations to pregnancy in people ≥35 years of age. Increased sympathetic nervous system activity and vasoconstrictor sensitivity both contribute to increases in vessel stiffness outside of pregnancy [31,32], and it is plausible that increases in these mechanisms without appropriate compensatory responses leads to increased resistance vessel stiffness in pregnant individuals of AMA. In support, aged Sprague Dawley rat dams display a greater vasoconstrictive phenotype compared with young dams [25]. Interestingly, a recent meta-regression analysis found that while sympathetic nervous system activity is augmented during normal pregnancy, this was not significantly associated with gestational age [33]. However, whether these normal increases are met with an equally appropriate adaptation, including reduced baroreflex sensitivity and increased endothelium-dependent dilation, to counterbalance the overall stiffening effects in AMA is unknown.
In general, endothelial function decreases with normal aging; however, it is unclear the effect this has during pregnancy in AMA. Similar to studies of arterial stiffening associated with aging, studies of the effects of aging on endothelial function usually define ‘aging’ at midlife (∼55–60 years) and beyond, often after the menopausal transition for women, and women of AMA would still be considered relatively young. Interestingly, aged pregnant rats had enhanced nitric oxide-dependent dilation in mesenteric arteries compared with young pregnant rats at term [25]. Moreover, placental arteries collected from women of AMA at delivery demonstrated increased endothelium-dependent dilation responses to bradykinin compared with young pregnant women [34]. This may indicate that in healthy pregnancies (i.e. without adverse maternal or fetal outcomes) at AMA, the endothelium overcompensates via enhanced nitric oxide production to meet metabolic demand in less compliant vessels. Whether an increased frequency in the inability to upregulate endothelium-dependent dilation in pregnant women ≥35 years underlies the increased incidence of adverse outcomes in these women is entirely unexplored. Although endothelial function was not examined by Wooldridge et al., omental arteries collected from women with a history of preeclampsia – a known state of systemic maternal endothelial dysfunction in pregnancy – found similar irregularities in collagen and elastin compared with vessels from normotensive pregnant women [34]. Thus, the findings from Wooldridge et al. may suggest similar reductions in endothelial function in maternal resistance arteries, contrary to findings seen in murine models. Given the known association of aging with impaired endothelium-dependent dilation, reductions in this mechanism may result in suboptimal vascular adaptations to pregnancy in women of AMA. Future work examining endothelial function of resistance arteries in AMA is required to determine whether alterations in this mechanism contribute to increased vessel stiffness in these women during pregnancy.
Overall, the work of Wooldridge and colleagues takes a valuable translational step as it examines omental artery stiffness in vitro in human vessels obtained from pregnant women of AMA compared with young pregnant controls. Their findings, that omental arteries from pregnant women ≥35 years of age were less compliant and had less elastin than arteries obtained from women <35 years of age, suggests that alterations in maternal resistance vessel stiffness may contribute to the increased risk of adverse outcomes associated with pregnancy at AMA. These results contribute to our understanding of vascular adaptations to pregnancy in AMA and highlight new directions and novel questions related to the mechanisms underpinning these alterations (Figure 1). It is well established that adverse maternal and fetal outcomes in pregnancy have lasting implications for health across the lifespan. Consequently, as the rates of pregnancy in women of AMA increases, studies of the underlying mechanisms contributing to increased risk of adverse outcomes in these pregnancies are compulsory in order to identify novel approaches to reduce risk and improve lifetime health for these women and their children.
Possible Mechanisms Underlying Increased Resistance Artery Stiffness in Advanced Maternal Age
Advanced maternal age (AMA, pregnancy at ≥35 years of age) is associated with increased omental artery stiffness – increased circumferential strain and decreased elastin content – at term (∼38–39 gestational weeks) compared with young (<35 years of age) pregnant women [7]. This increased stiffness may be due to an age-associated increase in pre-pregnancy resistance artery stiffness, a maladaptation to the cardiovascular demands of the pregnancy, or a combination of the two, driving changes in underlying vascular mechanisms. Plausible underlying mechanisms include reduced endothelium-dependent dilation, increased baroreflex sensitivity, and/or increased vasoconstrictor sensitivity, compared with pregnancy in healthy young women.
Advanced maternal age (AMA, pregnancy at ≥35 years of age) is associated with increased omental artery stiffness – increased circumferential strain and decreased elastin content – at term (∼38–39 gestational weeks) compared with young (<35 years of age) pregnant women [7]. This increased stiffness may be due to an age-associated increase in pre-pregnancy resistance artery stiffness, a maladaptation to the cardiovascular demands of the pregnancy, or a combination of the two, driving changes in underlying vascular mechanisms. Plausible underlying mechanisms include reduced endothelium-dependent dilation, increased baroreflex sensitivity, and/or increased vasoconstrictor sensitivity, compared with pregnancy in healthy young women.
Competing Interests
The authors declare that there are no competing interests associated with the manuscript.
CRediT Author Contribution
Anna E. Stanhewicz: Conceptualization, Writing—original draft, Writing—review & editing. Kelsey S. Schwartz: Conceptualization, Writing—original draft, Writing—review & editing. Ruda Lee: Conceptualization, Writing—original draft, Writing—review & editing.